Secant Medical to Discuss Creation and Commercialization of New Biomaterials at Society for Biomaterials 2015 Annual Meeting

March 31, 2015 | By Business Wire News

PERKASIE, Pa.

Emily Ho, director and general manager of advanced biomaterials at Secant Medical, will present “Building a New Biomaterial: From Creation to Commercialization” at the Society for Biomaterials 2015 Annual Meeting in Charlotte, NC on Friday, April 17. Ho will outline the challenges that manufacturers face during the scale-up of a new biomaterial, obstacles encountered at the commercialization stage, and potential domestic and international regulatory hurdles.

“The evolving trend in the healthcare industry is not just to save lives but also to restore quality of life to patients,” says Emily Ho. “The movement towards minimally invasive surgery and multi-functional devices is driving medical innovation and the development of new biomaterials.” Ho will discuss the path of poly(glycerol sebacate), a bioresorbable polymer, and how its characteristics could drive adoption in a diverse range of medical applications.

Secant Medical will be exhibiting poly(glycerol sebacate), also known as Regenerez®, as well as the company’s biomedical textile structures during the Society for Biomaterials 2015 Annual Meeting & Exposition, April 15-18, in Booth #301 at the Charlotte Convention Center.

Presentation: Building a New Biomaterial: From Creation to Commercialization, Cardiovascular Device Development and the Regulatory Process Panel
When: Friday, April 17, 2015, 10:30 am – 12:30 pm
Exhibition: Booth #301, April 15-18, 2015
Where: Charlotte Convention Center, Charlotte, NC

About Society for Biomaterials: The 2015 Annual Meeting of the Society for Biomaterials is the place where industry, academia and clinicians can gather to discuss the latest trends and scientific breakthroughs in the biomaterials field. The event is expected to host 1,400 of the nation’s leading experts in biomaterials science.

About Secant Medical: Secant Medical^® designs and manufactures biomedical textiles and other structures for medical devices. Employing medical fabric engineering technologies, we blend polymeric, metallic and resorbable biomaterials to create custom, high-performance structures that are used in the cardiovascular, general surgery, neurovascular, orthopedic and regenerative medicine fields. Built on a 70-year history, we’re committed to the future of biomaterials and their role in the healing process and are actively engaged in research partnerships to advance next-generation biomaterial development. Secant Medical is a business unit of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, contact 877-774-2835 or visit www.secantmedical.com.